Polina Stolyar is a highly experienced Principal Scientist specializing in in vivo and behavioral pharmacology within the field of neuroscience. Currently employed at AbbVie since August 2024, Stolyar previously held similar positions at Cerevel Therapeutics and Novartis Institutes for BioMedical Research. Stolyar's career in scientific research began at Pfizer, where several roles including Scientist and Senior Associate Scientist were undertaken over a decade. Earlier experience includes serving as a Research Assistant at Infinity Pharmaceuticals and as a Laboratory Research Assistant at Harvard School of Public Health. Stolyar holds a BS in Toxicology from Northeastern University and has pursued Continuing Education in Biology at Brown University.